Articles Vol. 67 No. Số CĐ12- Bệnh viện Ung bướu Nghệ An (2026) 25/08/2026

CLINICAL AND GENETIC CHARACTERISTICS OF ANDERSEN-TAWIL SYNDROME: THE FIRST FAMILIAL CASE SERIES IN VIETNAM

Bui Thuy Duong1,2, Tran Thi Ngoc Truong3,4, Luong Cong Thuc1,2
1 Cardiovascular Center, Military Hospital 103
2 Trung tâm Tim mạch, Bệnh viện Quân y 103
3 Department of Neurology, Military Hospital 103
4 Khoa Nội thần kinh, Bệnh viện Quân y 103
DOI: 10.52163/yhc.v67iCD12.6296
264 Views
0 Downloads
Abstract

Objective: To describe the clinical and electrocardiographic features and identify the genetic variant in a familial case series of Andersen-Tawil syndrome.

Subjects and methods: This descriptive retrospective-prospective study included the proband, an elder sister, and two first-degree relatives: her father and younger brother. Data were collected from medical history, previous investigations, and periodic follow-up of the proband. Genetic testing was performed using next-generation sequencing, with confirmation by Sanger sequencing.

Results: The elder sister presented with the typical clinical triad of Andersen-Tawil syndrome, including dysmorphic features, periodic paralysis, and bidirectional ventricular tachycardia. The younger brother had severe ventricular arrhythmias, which increased after unsuccessful radiofrequency catheter ablation. The father carried the variant but had no clinical manifestations. All three family members carried the heterozygous missense variant p.Asp71Gly (c.212A > G) in the KCNJ2 gene.

Conclusion: This is the first report from Vietnam identifying the p.Asp71Gly variant causing Andersen-Tawil syndrome type 1. The findings demonstrate marked intrafamilial phenotypic variability and highlight the role of genetic testing and Holter electrocardiographic monitoring in early screening for the risk of sudden cardiac death.

References
[1]
Pérez-Riera A.R, Barbosa-Barros R, Samesina N et al. Andersen-Tawil syndrome: a comprehensive review. Cardiol Rev, 2021, 29 (4): 165-177. doi: 10.1097/CRD.0000000000000326. Google Scholar
[2]
Zeppenfeld K, Tfelt-Hansen J, de Riva M et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J, 2022, 43 (40): 3997-4126. doi: 10.1093/eurheartj/ehac270. Google Scholar
[3]
Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, 17 (5): 405-424. doi: 10.1038/gim.2015.30. Google Scholar
[4]
Haruna Y, Kobori A, Makiyama T et al. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome. Hum Mutat, 2007, 28 (2): 208-221. doi: 10.1002/humu.9483. Google Scholar
[5]
Vivekanandam V, Männikkö R, Skorupinska I et al. Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity. Brain, 2022, 145 (6): 2108-2120. doi: 10.1093/brain/awab445. Google Scholar
[6]
Gnazzo M, Parlapiano G, Morlino S et al. Multisystemic assessment in Andersen-Tawil syndrome: report of eighteen individuals. Diagnostics, 2026, 16 (12): 1876. doi: 10.3390/diagnostics16121876. Google Scholar
[7]
Baher A.A, Uy M, Xie F et al. Bidirectional ventricular tachycardia: ping pong in the His-Purkinje system. Heart Rhythm, 2011, 8 (4): 599-605. doi: 10.1016/j.hrthm.2010.11.038. Google Scholar
[8]
Keegan R, Onetto L, Gregorietti F et al. Catheter ablation of frequent monomorphic ventricular arrhythmias in Andersen-Tawil syndrome: case report and focused literature review. J Interv Card Electrophysiol, 2022, 64 (2): 411-420. doi: 10.1007/s10840-021-01077-w. Google Scholar
[9]
Delannoy E, Sacher F, Maury P et al. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation. Europace, 2013, 15 (12): 1805-1811. doi: 10.1093/europace/eut160. Google Scholar
[10]
Kostera-Pruszczyk A, Potulska-Chromik A, Pruszczyk P et al. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement. Muscle Nerve, 2015, 51 (2): 192-196. doi: 10.1002/mus.24293 Google Scholar